Sitemap - 2025 - Alex Kesin's Pharmacopoeia
The Day Novartis Chose Discovery
Against "Against Life Extension"
Biotech Life in the Software City
Mr. Secretary, Reclassify the Statin
Playing Poker With Marty Makary
The Pageant of Responsible Longevity
What Skiing Really Means in San Francisco
China’s leap in pharma: slow and fast trends behind its rise
6 ways the new FDA can turbocharge drug development
Narrow Leverage: How Small Strengths Create Big Power
Prescription strength: musings about the past/present/future of sarcopenia therapeutics